share_log

HC Wainwright & Co. Reiterates Buy on Puma Biotechnology, Maintains $7 Price Target

Benzinga ·  Nov 8 11:40  · Ratings

HC Wainwright & Co. analyst Edward White reiterates Puma Biotechnology (NASDAQ:PBYI) with a Buy and maintains $7 price target.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment